George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJPMorgan American Regulatory News (JAM)

Share Price Information for JPMorgan American (JAM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 969.00
Bid: 969.00
Ask: 972.00
Change: 18.00 (1.89%)
Spread: 3.00 (0.31%)
Open: 958.00
High: 975.00
Low: 957.00
Prev. Close: 951.00
JAM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Results analysis from Kepler Trust Intelligence

28 Mar 2024 12:12

RNS Number : 7464I
JPMorgan American IT PLC
28 March 2024
 

JPMorgan American (JAM)

28/03/2024

Results analysis from Kepler Trust Intelligence

JPMorgan American (JAM) produced a net asset value total return of 24.7% in the year to 31/12/2023 compared to the trust's benchmark, the S&P 500, which produced an 18.9% total return. Since JAM implemented its current investment strategy on 01/06/2019 to the end of February, it has generated a NAV total return of 116.3% compared with a benchmark return of 97.3%, an annualised outperformance of 2.2 percentage points. 

This performance has, in our view, cemented JAM's position as a core holding, and even as the investment trust sector is on average experiencing very wide discounts, driven by sentiment and technical issues such as cost disclosures and the consolidation of the wealth management industry, a significant shareholder of investment trusts, JAM has retained a narrow discount or premium. JAM in our view provides a template for what a successful equity investment trust looks like: an investment proposition that is clearly understandable, adds value through a well-thought-out active strategy as well as through gearing, and which is able to step in and buy shares back when needed, without any particular concerns about what that might do to the portfolio mix, or to gearing. With M&A picking up speed in the investment trust sector, JAM is a good example for trusts wondering what the benefits of scale are w, not least because JAM's significant outperformance came with an ongoing charges figure of 0.38%.

 

CLICK HERE TO READ THE FULL REPORT  Visit Kepler Trust Intelligence for more high quality independent investment trust research.

 

Important information

This report has been issued by Kepler Partners LLP. The analyst who has prepared this report is aware that Kepler Partners LLP has a relationship with the company covered in this report and/or a conflict of interest which may impair the objectivity of the research.

Past performance is not a reliable indicator of future results. The value of investments can fall as well as rise and you may get back less than you invested when you decide to sell your investments. It is strongly recommended that if you are a private investor independent financial advice should be taken before making any investment or financial decision.

Kepler Partners is not authorised to make recommendations to retail clients. This report has been issued by Kepler Partners LLP, is based on factual information only, is solely for information purposes only and any views contained in it must not be construed as investment or tax advice or a recommendation to buy, sell or take any action in relation to any investment.

The information provided on this website is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation or which would subject Kepler Partners LLP to any registration requirement within such jurisdiction or country. In particular, this website is exclusively for non-US Persons. Persons who access this information are required to inform themselves and to comply with any such restrictions.

The information contained in this website is not intended to constitute, and should not be construed as, investment advice. No representation or warranty, express or implied, is given by any person as to the accuracy or completeness of the information and no responsibility or liability is accepted for the accuracy or sufficiency of any of the information, for any errors, omissions or misstatements, negligent or otherwise. Any views and opinions, whilst given in good faith, are subject to change without notice.

This is not an official confirmation of terms and is not a recommendation, offer or solicitation to buy or sell or take any action in relation to any investment mentioned herein. Any prices or quotations contained herein are indicative only.

Kepler Partners LLP (including its partners, employees and representatives) or a connected person may have positions in or options on the securities detailed in this report, and may buy, sell or offer to purchase or sell such securities from time to time, but will at all times be subject to restrictions imposed by the firm's internal rules. A copy of the firm's Conflict of Interest policy is available on request.

PLEASE SEE ALSO OUR TERMS AND CONDITIONS

Kepler Partners LLP is authorised and regulated by the Financial Conduct Authority (FRN 480590), registered in England and Wales at 70 Conduit Street, London W1S 2GF with registered number OC334771.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAMZGZFZRGGDZM
Date   Source Headline
26th Apr 20244:11 pmRNSIssue of Equity
26th Apr 202410:47 amRNSNet Asset Value(s)
25th Apr 20244:30 pmRNSIssue of Equity
25th Apr 202410:07 amRNSNet Asset Value(s)
24th Apr 20244:12 pmRNSIssue of Equity
24th Apr 202410:19 amRNSNet Asset Value(s)
23rd Apr 20244:29 pmRNSIssue of Equity
23rd Apr 20244:19 pmRNSIssue of Equity
23rd Apr 202410:31 amRNSNet Asset Value(s)
22nd Apr 202411:20 amRNSGearing announcement
22nd Apr 202410:48 amRNSNet Asset Value(s)
19th Apr 20245:04 pmRNSIssue of Equity
19th Apr 202410:26 amRNSNet Asset Value(s)
18th Apr 20244:58 pmRNSIssue of Equity
18th Apr 202410:52 amRNSNet Asset Value(s)
17th Apr 202410:43 amRNSNet Asset Value(s)
16th Apr 202410:29 amRNSNet Asset Value(s)
15th Apr 202411:39 amRNSGearing Anouncement
15th Apr 202410:33 amRNSNet Asset Value(s)
12th Apr 202410:59 amRNSNet Asset Value(s)
11th Apr 20243:24 pmRNSTen Largest Investments
11th Apr 202410:46 amRNSNet Asset Value(s)
10th Apr 202411:49 amRNSNet Asset Value(s)
9th Apr 202410:35 amRNSNet Asset Value(s)
8th Apr 202411:56 amRNSGearing Announcement
8th Apr 202410:31 amRNSNet Asset Value(s)
5th Apr 202410:40 amRNSNet Asset Value(s)
4th Apr 202410:40 amRNSNet Asset Value(s)
3rd Apr 202411:36 amRNSNet Asset Value(s)
2nd Apr 20242:45 pmRNSGearing Announcement
2nd Apr 20241:40 pmRNSNet Asset Value(s)
2nd Apr 202411:12 amRNSTotal Voting Rights
28th Mar 202412:12 pmRNSResults analysis from Kepler Trust Intelligence
28th Mar 202410:25 amRNSNet Asset Value(s)
27th Mar 202410:53 amRNSNet Asset Value(s)
27th Mar 20247:05 amRNSDividend Declaration
27th Mar 20247:00 amRNSAnnual Financial Report
26th Mar 202410:43 amRNSNet Asset Value(s)
25th Mar 202412:37 pmRNSGearing Announcement
25th Mar 202411:02 amRNSNet Asset Value(s)
22nd Mar 202411:10 amRNSNet Asset Value(s)
21st Mar 202410:42 amRNSNet Asset Value(s)
20th Mar 202410:35 amRNSNet Asset Value(s)
20th Mar 20248:00 amRNSRetirement of Portfolio Manager in Early 2025
19th Mar 202410:27 amRNSNet Asset Value(s)
18th Mar 202411:46 amRNSGearing Announcement
18th Mar 202411:08 amRNSNet Asset Value(s)
15th Mar 202411:09 amRNSNet Asset Value(s)
14th Mar 202410:53 amRNSNet Asset Value(s)
13th Mar 202410:22 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.